*Our key figures according to Swedish Fundraising Control differ from those above. This is because our calculation model includes interest income and similar income items from the Swedish Childhood Cancer Fund’s long-term security holdings.
To achieve our vision of eradicating childhood cancer, we need to provide more resources to research. It is also important that those suffering from childhood cancer – both the children and their families – get the advice and support they need and are entitled to. Our third mission, information, is crucial for the Swedish Childhood Cancer Fund to continue to fund research and provide vital advice and support. The information mission raises awareness and increases knowledge about childhood cancer and why your donation is important.
The Swedish Childhood Cancer Fund is the single largest financier of research into childhood cancer in Sweden. We also support the development of new treatment methods and professional training in paediatric oncology. The Fund granted a total of SEK 235 million in 2017 to causes such as:
We plan, arrange, and further develop important advice and support measures to children with cancer and their families. This contributes to providing children and their families an opportunity for rehabilitation and much-needed recreation. Initiatives in this area, amounting to about SEK 40 million in 2017, included:
We work actively to produce and distribute important information and to influence public opinion regarding the issue of cancers in children and teens, which includes initiatives to raise awareness and increase knowledge. The budget for the information mission, about SEK 52 million in 2017, was spent on measures such as:
Research is the mission that receives the largest proportion of the funds we raise. In this mission, research grants are allocated based on the cancers that affect the largest number of children, and for which we can contribute to the greatest progress in reducing the number of children who develop cancer. The illustration below shows the allocation of research grants in 2017 per type of cancer.